Recent pharma happenings: Incyte meets endpoint in the second pivotal #atopicdermatitis clinical trial; NeoTX Therapeutics lands USD 45 Million series C for combo I-O #cancer trials; A combo of the #pancreatic cancer of Five Prime Therapeutics with #Opdivo a bust; Visit to read more: https://www.delveinsight.com/blog/recent-pharma-happenings-for-incyte-neotx-five-prime/ #market #marketresearch #pharma #biotech #pharmanews #news